Bacteria and mucosal immunity

Digestive and Liver Disease

Volumn 38, Issue SUPPL. 2, 2006, Pages

  Monteleone, Giovanni ^a   Peluso, Ilaria ^a   Fina, Daniele ^a   Caruso, Roberta ^a   Andrei, Fabio ^a   Tosti, Claudio ^a   Pallone, Francesco ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Bacterial flora; Crohn's disease; IgA; Mucosal immune response; T cells

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; PROBIOTIC AGENT;

ARTICLE; BACTERIAL FLORA; CELLULAR IMMUNITY; CROHN DISEASE; CYTOKINE RELEASE; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSTIMULATION; INTESTINE EPITHELIUM; INTESTINE FLORA; LAMINA PROPRIA; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; T LYMPHOCYTE; TH1 CELL;

BACTERIA; HUMANS; IMMUNE TOLERANCE; INTESTINAL DISEASES; INTESTINAL MUCOSA;

EID: 33846437840     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(07)60005-X     Document Type: Article

References (46)

1. Pickard K., Bremner A., Gordon J., and MacDonald T. Microbial-gut interactions in health and disease. Immune responses. Best Pract Res Clin Gastroenterol 18 (2004) 271-285
2. Macpherson A., Hunziker L., McCoy K., and Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 3 (2001) 1021-1035
3. Moreau M., Ducluzeau R., Guy-Grand D., and Muller M. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun 21 (1978) 532-539
4. Logan A., Chow K., George A., Weinstein P., and Cebra J. Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii. Infect Immun 59 (1991) 1024-1031
5. Hooper L., Wong M., Thelin A., Hansson L., Falk P., and Gordon J. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
6. Umesaki Y., Setoyama H., Matsumoto S., Imaoka A., and Itoh K. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 67 (1999) 3504-3511
7. Bos N., Jiang H., and Cebra J. T cell control of the gut IgA response against commensal bacteria. Gut 48 (2001) 762-764
8. Gronlund M., Arvilommi H., Kero P., Lehtonen O., and Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed 83 (2000) F186-F192
9. Cebra J., Jiang H.-Q., Boiko N., and Tlaskalova-Hogenova H. The role of mucosal microbiota in the development, maintenance, and pathologies of the mucosal immune system. In: Mestecky J., Lamm M., Strober W., Bienenstock J., McGhee J., and Mayer L. (Eds). Mucosal Immunology Vol I (2005), Academic Press 335-368
10. Duchmann R., May E., Heike M., Knolle P., Neurath M., and Meyer zum Buschenfelde K. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 44 (1999) 812-818
11. Brimnes J., Reimann J., Nissen M., and Claesson M. Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. Eur J Immunol 31 (2001) 23-31
12. Cong Y., Brandwein S., McCabe R., Lazenby A., Birkenmeier E., Sundberg J., and Elson C. CD4+ T cells reactive to enteric bacterial antigens in spontaneously oolitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 187 (1998) 855-864
13. Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., and Meyer zum Buschenfelde K. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102 (1995) 448-455
14. Takeuchi O., and Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1 (2001) 625-635
15. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J., and Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2 (2001) 361-367
16. Niess J., Brand S., Gu X., Landsman L., Jung S., McCormick B., Vyas J., Boes M., Ploegh H., Fox J., Littman D., and Reinecker H. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
17. Eberl G. Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway?. Nat Rev Immunol 5 (2005) 413-420
18. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560 (2005) 11-18
19. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
20. Kaisho T., and Akira S. Regulation of dendritic cell function through toll-like receptors. Curr Mol Med 3 (2003) 759-771
21. Kellermann S., and McEvoy L. The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J Immunol 167 (2001) 682-690
22. Iwasaki A., and Kelsall B. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 190 (1999) 229-239
23. Hauer A., Bajaj-Elliott M., Williams C., Walker-Smith J., and MacDonald T. An analysis of interferon gamma, IL-4, IL-5 and IL-10 production by ELISPOT and quantitative reverse transcriptase-PCR in human Peyer's patches. Cytokine 10 (1998) 627-634
24. Nagata S., McKenzie C., Fender S., Bajaj-Elliott M., Fairclough P., Walker-Smith J., Monteleone G., and MacDonald T. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol 165 (2000) 5315-5321
25. Monteleone G., Holloway J., Salvati V., Fender S., Fairclough P., Croft N., and MacDonald T. Activated STAT4 and a functional role for IL-12 in human Peyer's patches. J Immunol 170 (2003) 300-307
26. MacDonald T., and Monteleone G. IL-12 and Thl immune responses in human Peyer's patches. Trends Immunol 22 (2001) 244-247
27. Mazmanian S., Liu C., Tzianabos A., and Kasper D. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (2005) 107-118
28. Neish A., Gewirtz A., Zeng H., Young A., Hobert M., Karmali V., Rao A., and Madara J. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289 (2000) 1560-1563
29. Kelly D., Campbell J., King T., Grant G., Jansson E., Coutts A., Pettersson S., and Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5 (2004) 104-112
30. Strauch U., Obermeier F., Grunwald N., Gurster S., Dunger N., Schultz M., Griese D., Mahler M., Scholmerich J., and Rath H. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 54 (2005) 1546-1552
31. Di Giacinto C., Marinaro M., Sanchez M., Strober W., and Boirivant M. Probiotics ameliorate recurrent Thl-mediated murine colitis by inducing IL-10 and IL-10 dependent TGF-beta-bearing regulatory cells. J Immunol 174 (2005) 3237-3246
32. Kiyono H., McGhee J., Wannemuehler J., and Michalek S. Lack of oral tolerance in C3H/HeJ mice. J Exp Med 155 (1982) 605-610
33. Moreau M., and Corthier G. Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice. Infect Immun 56 (1988) 2766-2768
34. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., and Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159 (1997) 1739-1745
35. Thukral C., Travassos W., and Peppercorn M. The Role of Antibiotics in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol 8 (2005) 223-228
36. Strober W., Fuss I., and Blumberg R. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
37. Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., and Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338 (1991) 771-774
38. D'Haens G., Geboes K., Peeters M., Baert F., Penninckx F., and Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 14 (1998) 262-267
39. Lodes M., Cong Y., Elson C., Mohamath R., Landers C., Targan S., Fort M., and Hershberg R. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 13 (2004) 1296-1306
40. Sitaraman S., Klapproth J., Moore III D., Landers C., Targan S., Williams I., and Gewirtz A. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 288 (2005) 0403-0406
41. Bibiloni R., Fedorak R., Tannock G., Madsen K., Gionchetti P., Campieri M., De Simone C., and Sartor R. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100 (2005) 1539-1546
42. Sartor R. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 (2004) 1620-1633
43. Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale?. Inflamm Bowel Dis 6 (2000) 107-115
44. Maassen C., van Holten-Neelen C., Balk F., den Bak-Glashouwer M., Leer R., Laman J., Boersma W., and Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18 (2000) 2613-2623
45. Mohamadzadeh M., Olson S., Kalina W., Ruthel G., Demmin G., Warfield K., Bavari S., and Klaenhammer T. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 102 (2005) 2880-2885
46. Hessle C., Hanson L., and Wold A. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 116 (1999) 276-282